Safety and Efficacy Study of Dapsone Gel in Patients With Acne Vulgaris

Completed · Phase 3

Conditions studied: Acne Vulgaris

In brief

This study will assess the safety and efficacy of dapsone gel versus vehicle control in patients with acne vulgaris.

Key facts

Study ID

NCT01974323

Run by

Almirall, S.A.

People needed

2238

Starts

2013-11-01

Expected to finish

2014-10-01

Last updated by the study team

2018-10-09

Who can join

Age: 12 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of acne vulgaris
• Willing to avoid excessive or prolonged exposure to ultraviolet light (eg, sunlight, tanning beds) throughout the study

You may not qualify if…

• Severe cystic acne, acne conglobata, acne fulminans, or secondary acne
• Use of phototherapy devices (eg, ClearLight™), energy-based devices, adhesive cleansing strips (eg, Pond's®, Biore®), or cosmetic procedures (eg, facials, peeling, comedo extraction) in the past week
• Use of anti-inflammatory medications, salicylic acid; corticosteroids, antibiotics, antibacterials (including benzoyl peroxide-containing products [eg, benzamycin]), retinoids; other topical acne treatments (eg, photodynamic therapy, medicated soaps such as those containing benzoyl peroxide, salicylic acid, sulfur, or sodium sulfacetamide) in the past 2 weeks
• Use of birth control pills strictly for acne control

Where it is running

• Study site — Beverly Hills, California, United States
• Study site — Aventura, Florida, United States
• Study site — Windsor, Ontario, Canada

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.